Paper699894
Antiepileptic drug development: II. Anticonvulsant drug screening.
Krall RL and 4 others. Epilepsia, 1978. Cited by 735 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Antiepileptic drug development: II. Anticonvulsant drug screening. Papers, record 699894. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/699894
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics14
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Anticonvulsants | Major topic |
| Drug Evaluation, Preclinical | Major topic |
| Animals | |
| Central Nervous System | |
| Dose-Response Relationship, Drug | |
| Drug Industry | |
| Electroshock | |
| Male | |
| Mice | |
| Motor Skills | |
| Pentylenetetrazole | |
| Quality Control | |
| Research Design | |
| Seizures |
Source PubMed
Cited by89
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 735 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42,133,160 | Design, synthesis and pharmacological evaluation of novel 2-aryloxazole-based H3 receptor antagonists as potent, antiseizure agents. | Mol Divers | 2026 | https://conductscience.org/library/papers/42133160 | PubMed |
| 42,023,289 | Epilepsy Therapy Screening From 1975 to 2026 and Beyond: Merging Established and New Approaches to Develop Novel Therapies. | Epilepsy Curr | 2026 | https://conductscience.org/library/papers/42023289 | PubMed |
| 40,871,553 | Design, Synthesis, and Pharmacological Activity of the N-(4-(1H-1,2,4-Triazol-1-yl)phenyl)-substituted-amide Derivatives. | Molecules | 2025 | https://conductscience.org/library/papers/40871553 | PubMed |
| 40,021,503 | Multi-targeted benzylpiperidine-isatin hybrids: Design, synthesis, biological and in silico evaluation as monoamine oxidases and acetylcholinesterase inhibitors for neurodegenerative disease therapies. | J Comput Aided Mol Des | 2025 | https://conductscience.org/library/papers/40021503 | PubMed |
| 39,097,848 | Rational Design, Synthesis, and Computational Investigation of Dihydropyridine [2,3-d] Pyrimidines as Polyphenol Oxidase Inhibitors with Improved Potency. | Protein J | 2024 | https://conductscience.org/library/papers/39097848 | PubMed |
| 39,018,000 | Disruption of adenosine metabolism increases risk of seizure-induced death despite decreased seizure severity. | Epilepsia | 2024 | https://conductscience.org/library/papers/39018000 | PubMed |
| 38,931,437 | Chemical Behavior and Bioactive Properties of Spinorphin Conjugated to 5,5'-Dimethyl- and 5,5'-Diphenylhydantoin Analogs. | Pharmaceuticals (Basel) | 2024 | https://conductscience.org/library/papers/38931437 | PubMed |
| 38,001,914 | Additive Anticonvulsant Profile and Molecular Docking Analysis of 5,5'-Diphenylhydantoin Schiff Bases and Phenytoin. | Biomedicines | 2023 | https://conductscience.org/library/papers/38001914 | PubMed |
| 37,798,599 | P/Q type (Cav2.1) Calcium Channel Blocker ω-Agatoxin IVA Alters Cleaved Caspase-3 and BDNF Expressions in the Rat Brain and Suppresses Seizure Activity. | Mol Neurobiol | 2024 | https://conductscience.org/library/papers/37798599 | PubMed |
| 37,719,765 | Toward the use of novel alternative methods in epilepsy modeling and drug discovery. | Front Neurol | 2023 | https://conductscience.org/library/papers/37719765 | PubMed |
| 37,704,057 | Elevated susceptibility to exogenous seizure triggers and impaired interneuron excitability in a mouse model of Leigh syndrome epilepsy. | Neurobiol Dis | 2023 | https://conductscience.org/library/papers/37704057 | PubMed |
| 37,685,950 | Identification of New Antiseizure Medication Candidates in Preclinical Animal Studies. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/37685950 | PubMed |
| 37,175,408 | Zebrafish as an Innovative Tool for Epilepsy Modeling: State of the Art and Potential Future Directions. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/37175408 | PubMed |
| 37,043,151 | Chemical composition and anticonvulsant activities of herb pair of Gastrodia elata Blume-Acorus tatarinowii Schott decoction on experimentally induced seizures in mice. | Metab Brain Dis | 2023 | https://conductscience.org/library/papers/37043151 | PubMed |
| 36,687,046 | Design, Synthesis, In Vivo, and In Silico Evaluation of Benzothiazoles Bearing a 1,3,4-Oxadiazole Moiety as New Antiepileptic Agents. | ACS Omega | 2023 | https://conductscience.org/library/papers/36687046 | PubMed |
| 36,196,086 | Diaphragmatic pacing for the prevention of sudden unexpected death in epilepsy. | Brain Commun | 2022 | https://conductscience.org/library/papers/36196086 | PubMed |
| 34,978,007 | Investigation of the structure-activity relationship in a series of new LVV- and VV-hemorphin-7 analogues designed as potential anticonvulsant agents. | Amino Acids | 2022 | https://conductscience.org/library/papers/34978007 | PubMed |
| 34,618,296 | Anticonvulsant activity of methanolic extract of Withania cogulans in mice. | Metab Brain Dis | 2021 | https://conductscience.org/library/papers/34618296 | PubMed |
| 34,427,842 | PTZ kindling model for epileptogenesis, refractory epilepsy, and associated comorbidities: relevance and reliability. | Metab Brain Dis | 2021 | https://conductscience.org/library/papers/34427842 | PubMed |
| 34,209,381 | The Bucherer-Bergs Multicomponent Synthesis of Hydantoins-Excellence in Simplicity. | Molecules | 2021 | https://conductscience.org/library/papers/34209381 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/699894
GET https://conductscience.org/api/papers/v1/699894/cited_by?page=2